Results 231 to 240 of about 357,374 (264)

Cavitary pulmonary metastasis from renal pelvic urothelial carcinoma with pathological evidence of bronchiolar obstruction supporting a check-valve mechanism: a case report. [PDF]

Respir Med Case Rep
Nakano K, Nakagawa T, Kishi H, Fujino S, Ishihara T, Ohara M, Matsuo K, Higeta T, Maita K, Kobayashi H, Yamada M, Masuda R.   +11 more
europepmc   +1 more source

Beyond Tradition: An Integrated Toxicological, Ecological, and Public Health Perspective on Aristolochic Acids

Journal of Applied Toxicology, EarlyView.
ABSTRACT Aristolochia species have long been used in traditional medicine for their presumed anti‐inflammatory, analgesic and antimicrobial properties. However, extensive toxicological and epidemiological evidence now demonstrates that these plants contain aristolochic acids (AAs) I and II, highly potent nephrotoxic, genotoxic, and carcinogenic ...
Victor Ventura de Souza, Lara Rodrigues De Andrade, Tatiana da Silva Souza   +2 more
wiley   +1 more source

Venous Tumor Thrombus Level in Renal Cell Carcinoma: Impact on Surgical and Oncologic Outcomes. [PDF]

Cancers (Basel)
Korbecka Z, Jabłońska B, Król R.
europepmc   +1 more source

Protective Effects of Imeglimin Against Oxaliplatin‐Induced Peripheral Neurotoxicity: Evidence From In Vitro and In Vivo Studies

Journal of Applied Toxicology, EarlyView.
ABSTRACT Oxaliplatin is a platinum‐based anticancer agent widely used for gastrointestinal malignancies; however, it is known to cause dose‐dependent peripheral neuropathy (OIPN), a characteristic adverse effect. OIPN results in a reduced quality of life and often necessitates dose reduction or discontinuation of oxaliplatin; however, effective ...
Yusuke Koura, Kano Kinjo, Keisuke Mine, Yusuke Mori, Mami Ueda, Risa Kaneko, Yuna Kamiya, Taiga Sonoda, Haruka Mimata, Shunsuke Fujita, Takehiro Kawashiri, Daisuke Kobayashi   +11 more
wiley   +1 more source

Spontaneous Regression of Clear Cell Renal Cell Carcinoma Metastases or Immune Restoration? [PDF]

Curr Oncol
Vacheret C, Moinard-Butot F, Reberol L, Ciccolini A, Cazzato RL, Barthélémy P.   +5 more
europepmc   +1 more source

Serum Midkine as a Biomarker for Hepatocellular Carcinoma Treatment Response and Prognostication

Journal of Clinical Laboratory Analysis, EarlyView.
Up‐to‐date, tumor markers are considered more helpful in the evaluation of treatment response and prognostication rather than diagnosis. Identifying a valid biomarker to help clinical management of hepatocellular carcinoma (HCC) is still a challenge, especially the alpha‐fetoprotein (AFP) negative HCC. This study evaluated the efficacy of serum Midkine
Yanfang Luo, Qiuwei Lu, Jing Huang, Liejun Jiang   +3 more
wiley   +1 more source

Quantitative Diffusion-weighted Imaging in Eosinophilic Solid and Cystic Renal Cell Carcinoma. [PDF]

Radiol Imaging Cancer
Glessgen CG, Tille JC, Benamran D, Thoeny HC.   +3 more
europepmc   +1 more source

First-in-human <i>ex-vivo</i> validation of carbonic anhydrase IX-PET for high-risk renal cancer (CAT-VHL - PNRR-POC-2023-12377493). [PDF]

Theranostics
Larcher A, Gelardi F, Antunovic L, Savi A, Olivieri M, Rainone P, Sollini M, Moresco RM, Re C, Cei F, Belladelli F, Musso G, Salerno L, De Cobelli F, Tenace N, Ponzoni M, Cigliola A, Verze P, Bertini R, Briganti A, Montorsi F, Capitanio U, Salonia A, Chiti A.   +23 more
europepmc   +1 more source

[Corrigendum] ENO2 affects the EMT process of renal cell carcinoma and participates in the regulation of the immune micro-environment. [PDF]

Oncol Rep
Chen WJ, Yang W, Gong M, He Y, Xu D, Chen JX, Chen WJ, Li WY, Wang YQ, Dong KQ, Song X, Pan XW, Cui XG.   +12 more
europepmc   +1 more source

1H MR-based detection of human plasma metabolic alterations in clear cell renal cell carcinoma. [PDF]

BJUI Compass
Sharma RK, Solaiyappan M, Feinaj A, Brönimann S, Singla N, Bhujwalla ZM, Ged Y.   +6 more
europepmc   +1 more source